- Home
- IQV vs LEN Comparison
IQV vs LEN Comparison
Compare IQV & LEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- LEN
- Stock Information
- Founded
- IQV 1982
- LEN 1954
- Country
- IQV United States
- LEN United States
- Employees
- IQV N/A
- LEN N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- LEN Homebuilding
- Sector
- IQV Health Care
- LEN Consumer Discretionary
- Exchange
- IQV Nasdaq
- LEN Nasdaq
- Market Cap
- IQV 25.6B
- LEN 28.5B
- IPO Year
- IQV 2013
- LEN N/A
- Fundamental
- Price
- IQV $164.71
- LEN $115.31
- Analyst Decision
- IQV Buy
- LEN Hold
- Analyst Count
- IQV 20
- LEN 18
- Target Price
- IQV $226.80
- LEN $131.38
- AVG Volume (30 Days)
- IQV 2.3M
- LEN 3.6M
- Earning Date
- IQV 07-22-2025
- LEN 06-16-2025
- Dividend Yield
- IQV N/A
- LEN 1.73%
- EPS Growth
- IQV 0.26
- LEN N/A
- EPS
- IQV 7.35
- LEN 12.16
- Revenue
- IQV $15,497,000,000.00
- LEN $35,371,977,000.00
- Revenue This Year
- IQV $5.40
- LEN $1.88
- Revenue Next Year
- IQV $5.20
- LEN $4.20
- P/E Ratio
- IQV $22.14
- LEN $9.50
- Revenue Growth
- IQV 2.84
- LEN N/A
- 52 Week Low
- IQV $134.65
- LEN $98.42
- 52 Week High
- IQV $252.88
- LEN $187.61
- Technical
- Relative Strength Index (RSI)
- IQV 67.30
- LEN 61.32
- Support Level
- IQV $155.15
- LEN $107.87
- Resistance Level
- IQV $167.32
- LEN $118.38
- Average True Range (ATR)
- IQV 4.14
- LEN 3.86
- MACD
- IQV 0.69
- LEN 0.71
- Stochastic Oscillator
- IQV 81.76
- LEN 80.63
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About LEN Lennar Corporation
Lennar is one of the largest public homebuilders in the United States. The company's homebuilding operations target first-time, move-up, active adult, and luxury homebuyers mainly under the Lennar brand name. Lennar's financial services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily and single-family for-rent construction and has invested in numerous housing-related technology startups.